Trial intelligence / Profile preview

Naratriptan versus paracetamol preference crossover trial in migraine

NL-OMON22893Active, not recruiting

Start
Jan 2005
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of naratriptan and acetaminophen in migraine (2 arms). Primary endpoint: Patient preference. Started Jan 2005; status: active, not recruiting.

02

Drugs

naratriptanacetaminophen
03

Conditions

migraine

Beyond the preview

Go deeper on NL-OMON22893.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON22893.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call